Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Ivermectin Versus Albendazole for Chronic Strongyloidiasis

NCT00765024 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT00765024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00765024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Ivermectin Versus Albendazole for Chronic Strongyloidiasis
Lead sponsor
Mahidol University
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2008
Completion date
April 30, 2010
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic strongyloidiasis